Thus, our research question focused more on the mechanism underlying the association between pre‐diagnostic obesity and mortality, making the assessment of pre‐diagnostic FABP‐4 as an obesity biomarker particularly relevant. The gene discussed is FABP4; the disease is obesity disorder.